Oxurion NV (XBRU:OXUR) Days Sales Outstanding : 4,843.95 (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Oxurion NV Days Sales Outstanding?

Oxurion NV's average Accounts Receivable for the six months ended in Dec. 2023 was €2.20 Mil. Oxurion NV's Revenue for the six months ended in Dec. 2023 was €0.08 Mil. Hence, Oxurion NV's Days Sales Outstanding for the six months ended in Dec. 2023 was 4,843.95.

The historical rank and industry rank for Oxurion NV's Days Sales Outstanding or its related term are showing as below:

XBRU:OXUR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 121.77 Med: 197.74 Max: 2184.45
Current: 2184.45

During the past 13 years, Oxurion NV's highest Days Sales Outstanding was 2184.45. The lowest was 121.77. And the median was 197.74.

XBRU:OXUR's Days Sales Outstanding is ranked worse than
98.2% of 891 companies
in the Biotechnology industry
Industry Median: 71.97 vs XBRU:OXUR: 2184.45

Oxurion NV's Days Sales Outstanding increased from Dec. 2022 (896.97) to Dec. 2023 (4,843.95).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Oxurion NV Days Sales Outstanding Historical Data

The historical data trend for Oxurion NV's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV Days Sales Outstanding Chart

Oxurion NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

176.44

219.04

124.90

121.77

299.08

Oxurion NV Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															304.05	1,073.24	896.97	2,335.49	4,843.95

Competitive Comparison of Oxurion NV's Days Sales Outstanding

For the Biotechnology subindustry, Oxurion NV's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxurion NV's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxurion NV's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Oxurion NV's Days Sales Outstanding falls into.

Oxurion NV Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Oxurion NV's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.316	+	0.115)	/	2 )	/	0.263	*	365
=	0.2155					/	0.263	*	365
=	299.08

Oxurion NV's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (4.291	+	0.115)	/	2 )	/	0.083	*	365 / 2
=	2.203					/	0.083	*	365 / 2
=	4,843.95

Oxurion NV (XBRU:OXUR) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Oxurion NV Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Oxurion NV's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxurion NV (XBRU:OXUR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (XBRU:OXUR) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

TG4:Germany

Address

Gaston Geenslaan 1, Leuven, BEL, B-3001

Website

https://www.oxurion.com

Oxurion NV is a clinical stage biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME). The Group's research and development facilities are located in Belgium .The Company is engaged in the development of drugs to treat back-of-the-eye diseases, more specifically, ophthalmologic pharmaceuticals to treat vascular retinal disorders, specifically DME.

Oxurion NV (XBRU:OXUR) Headlines

No Headlines